Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
YSON-001 by Yisheng Biopharma for Solid Tumor: Likelihood of Approval
YSON-001 is under clinical development by Yisheng Biopharma and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
YSON-001 by Yisheng Biopharma for Metastatic Liver Cancer: Likelihood of Approval
YSON-001 is under clinical development by Yisheng Biopharma and currently in Phase I for Metastatic Liver Cancer. According to GlobalData,...
YSON-001 by Yisheng Biopharma for Metastatic Breast Cancer: Likelihood of Approval
YSON-001 is under clinical development by Yisheng Biopharma and currently in Phase I for Metastatic Breast Cancer. According to GlobalData,...